WO2000042045A3 - Functionalized heterocycles as chemokine receptor modulators - Google Patents
Functionalized heterocycles as chemokine receptor modulators Download PDFInfo
- Publication number
- WO2000042045A3 WO2000042045A3 PCT/US1999/030434 US9930434W WO0042045A3 WO 2000042045 A3 WO2000042045 A3 WO 2000042045A3 US 9930434 W US9930434 W US 9930434W WO 0042045 A3 WO0042045 A3 WO 0042045A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chemokine receptor
- receptor modulators
- useful
- functionalized heterocycles
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
Abstract
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL99349348A PL349348A1 (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as chemokine receptor modulators |
EP99963110A EP1144415A2 (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as chemokine receptor modulators |
CA002372197A CA2372197A1 (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as chemokine receptor modulators |
HU0202932A HUP0202932A3 (en) | 1999-01-13 | 1999-12-20 | Heterocyclic compounds and pharmaceutical compositions can be used as chemokine receptor modulators |
AU19409/00A AU1940900A (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as chemokine receptor modulators |
IL14428999A IL144289A0 (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as chemokine receptor modulators |
BR9916905-3A BR9916905A (en) | 1999-01-13 | 1999-12-20 | Compound, pharmaceutical composition, methods to modulate the activity of a chemokine receptor, to prevent HIV infection, to treat HIV infection, to delay the onset of AIDS, or to treat AIDS and to treat an inflammatory disease, and, combination |
EA200100774A EA200100774A1 (en) | 1999-01-13 | 1999-12-20 | HYDRONIC |
SK997-2001A SK9972001A3 (en) | 1999-01-13 | 1999-12-20 | Quinolizine derivative, pharmaceutical composition containing same and use thereof |
KR1020017008905A KR20010086166A (en) | 1999-01-13 | 1999-12-20 | Functionalized Heterocycles as Chemokine Receptor Modulators |
APAP/P/2001/002228A AP2001002228A0 (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as chemokine receptor modulators. |
JP2000593612A JP2002534526A (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as modulators of chemokine receptors |
MXPA01007033A MXPA01007033A (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as chemokine receptor modulators. |
NO20013456A NO20013456L (en) | 1999-01-13 | 2001-07-12 | Functionalized heterocycles as chemokine receptor modulators |
HK02106357.2A HK1044539A1 (en) | 1999-01-13 | 2002-08-28 | Functionalized heterocycles as chemokine receptor modulators |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11565499P | 1999-01-13 | 1999-01-13 | |
US60/115,654 | 1999-01-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000042045A2 WO2000042045A2 (en) | 2000-07-20 |
WO2000042045A3 true WO2000042045A3 (en) | 2000-11-09 |
Family
ID=22362668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/030434 WO2000042045A2 (en) | 1999-01-13 | 1999-12-20 | Functionalized heterocycles as chemokine receptor modulators |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1144415A2 (en) |
JP (1) | JP2002534526A (en) |
KR (1) | KR20010086166A (en) |
CN (1) | CN1344270A (en) |
AP (1) | AP2001002228A0 (en) |
AU (1) | AU1940900A (en) |
BR (1) | BR9916905A (en) |
CA (1) | CA2372197A1 (en) |
CZ (1) | CZ20012502A3 (en) |
EA (1) | EA200100774A1 (en) |
HK (1) | HK1044539A1 (en) |
HU (1) | HUP0202932A3 (en) |
IL (1) | IL144289A0 (en) |
MX (1) | MXPA01007033A (en) |
NO (1) | NO20013456L (en) |
OA (1) | OA11820A (en) |
PL (1) | PL349348A1 (en) |
SK (1) | SK9972001A3 (en) |
WO (1) | WO2000042045A2 (en) |
ZA (1) | ZA200106592B (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6951848B2 (en) | 2001-03-12 | 2005-10-04 | Millennium Pharmaceuticals, Inc., | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
HU230322B1 (en) | 2001-03-29 | 2016-01-28 | Eli Lilly And Co. | N-(2-arylethyl)-benzylamines as antagonists of the 5-ht6 receptor and pharmaceutical compositions containing them |
WO2003035650A1 (en) * | 2001-09-25 | 2003-05-01 | Takeda Chemical Industries, Ltd. | Entry inhibitor |
TWI344955B (en) | 2003-03-14 | 2011-07-11 | Ono Pharmaceutical Co | Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient |
US7498323B2 (en) | 2003-04-18 | 2009-03-03 | Ono Pharmaceuticals Co., Ltd. | Spiro-piperidine compounds and medicinal use thereof |
PE20060598A1 (en) | 2004-09-13 | 2006-08-21 | Ono Pharmaceutical Co | HETEROCYCLE DERIVATIVE CONTAINING NITROGEN AS ANTAGONIST OF CCR5 CHEMOKINE |
EP1889622A4 (en) | 2005-05-31 | 2009-12-23 | Ono Pharmaceutical Co | Spiropiperidine compound and medicinal use thereof |
US7915286B2 (en) | 2005-09-16 | 2011-03-29 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
WO2007049771A1 (en) | 2005-10-28 | 2007-05-03 | Ono Pharmaceutical Co., Ltd. | Compound containing basic group and use thereof |
ES2407115T3 (en) | 2005-11-18 | 2013-06-11 | Ono Pharmaceutical Co., Ltd. | Compound containing a basic group and its use |
CN101460458A (en) | 2006-02-15 | 2009-06-17 | 阿勒根公司 | Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
EP1984334B1 (en) * | 2006-02-15 | 2014-04-09 | Allergan, Inc. | Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
EP1995246A4 (en) | 2006-03-10 | 2010-11-17 | Ono Pharmaceutical Co | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
JP5257068B2 (en) | 2006-05-16 | 2013-08-07 | 小野薬品工業株式会社 | Compound containing acidic group which may be protected and use thereof |
WO2007136300A2 (en) * | 2006-05-23 | 2007-11-29 | Alla Chem, Llc | Substituted indoles and a method for the production and use thereof |
US20090325992A1 (en) | 2006-07-31 | 2009-12-31 | Ono Pharmaceutical Co., Ltd. | Compound having cyclic group bound thereto through spiro binding and use thereof |
US8524917B2 (en) | 2007-01-11 | 2013-09-03 | Allergan, Inc. | 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
JP2010515750A (en) * | 2007-01-11 | 2010-05-13 | アラーガン インコーポレイテッド | 6-Substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
CA2799154A1 (en) | 2010-05-12 | 2011-11-17 | Abbvie Inc. | Indazole inhibitors of kinase |
US20140271680A1 (en) | 2011-08-12 | 2014-09-18 | Universite Paris-Est Creteil Val De Marne | Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
JO3459B1 (en) | 2012-09-09 | 2020-07-05 | H Lundbeck As | Pharmaceutical compositions for treating alzheimer's disease |
CN104193669B (en) * | 2014-08-01 | 2016-12-07 | 大连理工大学 | One class Abiduoer analog or its salt, its preparation method and application |
WO2016112088A1 (en) * | 2015-01-06 | 2016-07-14 | Spero Therapeutics, Inc. | Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors |
CN110256324A (en) * | 2019-06-13 | 2019-09-20 | 苏州莱安医药化学技术有限公司 | A kind of preparation method of 2- methyl -5-OHi |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3518258A (en) * | 1967-05-09 | 1970-06-30 | Warner Lambert Pharmaceutical | Pyrano(3,2-i)quinolizine and process for the production |
US3549641A (en) * | 1966-06-28 | 1970-12-22 | Warner Lambert Pharmaceutical | Pyrano pyridines and process for their production |
US3565903A (en) * | 1967-11-24 | 1971-02-23 | Warner Lambert Pharmaceutical | Pyrano(2,3-b)quinolines and process for their production |
US5635510A (en) * | 1993-05-06 | 1997-06-03 | Merrell Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
EP0820998A2 (en) * | 1996-07-26 | 1998-01-28 | PLIVA, farmaceutska, kemijska, prehrambena i kozmeticka industrija dionicko drustvo | Novel coumarin quinolone carboxylic acids and processes for the preparation thereof |
WO1998038167A1 (en) * | 1997-02-26 | 1998-09-03 | Pfizer Inc. | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
WO1999038514A1 (en) * | 1998-02-02 | 1999-08-05 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
-
1999
- 1999-12-20 CN CN99816475A patent/CN1344270A/en active Pending
- 1999-12-20 SK SK997-2001A patent/SK9972001A3/en unknown
- 1999-12-20 BR BR9916905-3A patent/BR9916905A/en not_active Application Discontinuation
- 1999-12-20 EA EA200100774A patent/EA200100774A1/en unknown
- 1999-12-20 PL PL99349348A patent/PL349348A1/en not_active Application Discontinuation
- 1999-12-20 IL IL14428999A patent/IL144289A0/en unknown
- 1999-12-20 HU HU0202932A patent/HUP0202932A3/en unknown
- 1999-12-20 MX MXPA01007033A patent/MXPA01007033A/en unknown
- 1999-12-20 OA OA1200100187A patent/OA11820A/en unknown
- 1999-12-20 CZ CZ20012502A patent/CZ20012502A3/en unknown
- 1999-12-20 EP EP99963110A patent/EP1144415A2/en not_active Withdrawn
- 1999-12-20 JP JP2000593612A patent/JP2002534526A/en active Pending
- 1999-12-20 KR KR1020017008905A patent/KR20010086166A/en not_active Application Discontinuation
- 1999-12-20 AP APAP/P/2001/002228A patent/AP2001002228A0/en unknown
- 1999-12-20 WO PCT/US1999/030434 patent/WO2000042045A2/en not_active Application Discontinuation
- 1999-12-20 AU AU19409/00A patent/AU1940900A/en not_active Abandoned
- 1999-12-20 CA CA002372197A patent/CA2372197A1/en not_active Abandoned
-
2001
- 2001-07-12 NO NO20013456A patent/NO20013456L/en not_active Application Discontinuation
- 2001-08-10 ZA ZA200106592A patent/ZA200106592B/en unknown
-
2002
- 2002-08-28 HK HK02106357.2A patent/HK1044539A1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3549641A (en) * | 1966-06-28 | 1970-12-22 | Warner Lambert Pharmaceutical | Pyrano pyridines and process for their production |
US3518258A (en) * | 1967-05-09 | 1970-06-30 | Warner Lambert Pharmaceutical | Pyrano(3,2-i)quinolizine and process for the production |
US3565903A (en) * | 1967-11-24 | 1971-02-23 | Warner Lambert Pharmaceutical | Pyrano(2,3-b)quinolines and process for their production |
US5635510A (en) * | 1993-05-06 | 1997-06-03 | Merrell Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
EP0820998A2 (en) * | 1996-07-26 | 1998-01-28 | PLIVA, farmaceutska, kemijska, prehrambena i kozmeticka industrija dionicko drustvo | Novel coumarin quinolone carboxylic acids and processes for the preparation thereof |
WO1998038167A1 (en) * | 1997-02-26 | 1998-09-03 | Pfizer Inc. | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
WO1999038514A1 (en) * | 1998-02-02 | 1999-08-05 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
Non-Patent Citations (1)
Title |
---|
M. VON STRANDTMANN ET AL.: "Reaction of Phenolic Mannich Bases with Enamines. General Synthesis of Pyran-Containing Fused Ring Systems.", JOURNAL OF HETEROCYCLIC CHEMISTRY., vol. 7, 1970, HETEROCORPORATION. PROVO., US, pages 1311 - 1319, XP002143638, ISSN: 0022-152X * |
Also Published As
Publication number | Publication date |
---|---|
KR20010086166A (en) | 2001-09-08 |
CA2372197A1 (en) | 2000-07-20 |
CZ20012502A3 (en) | 2002-03-13 |
OA11820A (en) | 2005-08-17 |
MXPA01007033A (en) | 2003-07-21 |
HK1044539A1 (en) | 2002-10-25 |
NO20013456D0 (en) | 2001-07-12 |
HUP0202932A2 (en) | 2002-12-28 |
JP2002534526A (en) | 2002-10-15 |
EA200100774A1 (en) | 2002-02-28 |
IL144289A0 (en) | 2002-05-23 |
NO20013456L (en) | 2001-09-12 |
PL349348A1 (en) | 2002-07-15 |
WO2000042045A2 (en) | 2000-07-20 |
AP2001002228A0 (en) | 2001-09-30 |
AU1940900A (en) | 2000-08-01 |
ZA200106592B (en) | 2002-08-12 |
SK9972001A3 (en) | 2002-03-05 |
EP1144415A2 (en) | 2001-10-17 |
HUP0202932A3 (en) | 2003-07-28 |
BR9916905A (en) | 2002-01-29 |
CN1344270A (en) | 2002-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000042045A3 (en) | Functionalized heterocycles as chemokine receptor modulators | |
WO2002100844A3 (en) | Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | |
AU6461600A (en) | Substituted piperidine compounds useful as modulators of chemokine receptor activity | |
WO2004071426A3 (en) | Compounds for the treatment of viral infection | |
WO2000059497A8 (en) | Pyrrolidine modulators of chemokine receptor activity | |
CA2400268A1 (en) | Pyrrolopyrimidinone derivatives, process of preparation and use | |
MY125749A (en) | Aralkyl and aralkylidene heterocyclic lactams and imides | |
CA2243504A1 (en) | New 19-nor-pregnene derivatives | |
WO2004042351A3 (en) | Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity | |
AU4949800A (en) | 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives | |
MY123193A (en) | Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same | |
IL147149A0 (en) | Novel diphenyl-piperidine derivate | |
EE200200208A (en) | Oligosaccharides, process for their preparation and use, and pharmaceutical compositions | |
WO2004041777A3 (en) | Heteroarylpiperidine modulators of chemokine receptor activity | |
AU2001232556A1 (en) | Pyrimidine compounds and their use as modulators of chemokine receptor activity | |
AU667593B2 (en) | Inhibitors of HIV protease useful for the treatment of AIDS | |
FR2715402B1 (en) | New phenylimidazolines optionally substituted, their process and preparation intermediates, their use as medicaments and the pharmaceutical compositions containing them. | |
WO2001000617A3 (en) | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same | |
WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
AU5692500A (en) | Piperazine derivatives as modulators of chemokine receptor activity | |
AU2002322082A1 (en) | Pharmaceutical composition for the treatment of viral infection | |
WO2000072833A3 (en) | Pharmaceutical preparations for inhibiting sphingomyelinase | |
TR200003797T2 (en) | New preparations derived from alpha-D-xylose, their preparation methods and uses for treatment. | |
WO2000037465A3 (en) | Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents | |
WO2002055454A3 (en) | Process and product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99816475.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-2502 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/007033 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2372197 Country of ref document: CA Ref document number: 2372197 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 144289 Country of ref document: IL Ref document number: 9972001 Country of ref document: SK |
|
ENP | Entry into the national phase |
Ref document number: 2000 593612 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017008905 Country of ref document: KR Ref document number: A 2001 00806 Country of ref document: RO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999963110 Country of ref document: EP Ref document number: IN/PCT/2001/1088/CHE Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 513435 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/06592 Country of ref document: ZA Ref document number: 200106592 Country of ref document: ZA Ref document number: 19409/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200100774 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017008905 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999963110 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09889315 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-2502 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999963110 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-2502 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017008905 Country of ref document: KR |